Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.

by Alan C H Lee, Joanne K Y Lam, Sammy W M Shiu, Ying Wong, D John Betteridge, Kathryn C B Tan
Published 2015-01-01

Normal levels of inflammatory markers in treated patients with familial hypercholesterolaemia: a cross-sectional study

by Mary Seed, D John Betteridge, Jackie Cooper, Muriel Caslake, Paul N Durrington, Gilbert R Thompson, Naveed Sattar, Steve E Humphries, H Andrew W Neil
Published 2012-06-01

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)

by Harshal A. Deshmukh, Helen M. Colhoun, Toby Johnson, Paul M. McKeigue, D. John Betteridge, Paul N. Durrington, John H. Fuller, Shona Livingstone, Valentine Charlton-Menys, Andrew Neil, Neil Poulter, Peter Sever, Denis C. Shields, Alice V. Stanton, Aurobindo Chatterjee, Craig Hyde, Roberto A. Calle, David A. DeMicco, Stella Trompet, Iris Postmus, Ian Ford, J. Wouter Jukema, Mark Caulfield, Graham A. Hitman
Published 2012-05-01

CDKN2B expression in adipose tissue of familial combined hyperlipidemia patients[S]

by Stuart D. Horswell, Lee G.D. Fryer, Claire E. Hutchison, Dlear Zindrou, Helen E. Speedy, Margaret-M. Town, Emma J. Duncan, Rasheeta Sivapackianathan, Hetal N. Patel, Emma L. Jones, Adam Braithwaite, Max P.A. Salm, Claire K.Y. Neuwirth, Elizabeth Potter, Jonathan R. Anderson, Kenneth M. Taylor, Mary Seed, D. John Betteridge, Martin A. Crook, Anthony S. Wierzbicki, James Scott, Rossi P. Naoumova, Carol C. Shoulders
Published 2013-12-01